Latest Wellcome Trust Stories
DANVILLE, Pa., Jan. 30, 2015 /PRNewswire-USNewswire/ -- David H.
Strategic addition to help Tute Genomics power the genome revolution, enable genome-guided personalized medicine. PROVO, Utah, Jan.
For the first time, a nationwide project designed to use genetics to diagnose rare diseases will allow recent massive advances in genomics to translate into patient care in the UK’s National Health Service (NHS).
CAMBRIDGE, Massachusetts, November 17, 2014 /PRNewswire/ -- Direct linking between exome data in DECIPHER and European Journal of
Irys System to be employed in research to improve the quality of the human reference genome SAN DIEGO and ST. LOUIS, Oct.
- $5.8 million award will help advance the development of oxygen-carrying therapeutics for cancer - SAN CARLOS, Calif., Oct.
NOK 16 million awarded to develop novel cancer therapeutics BERGEN, Norway, September 23, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology
Unprecedented international consortium -- including the University of Maryland School of Medicine and NIH -- now assembled to accelerate collaborative multi-site trials of candidate Ebola vaccine
SAN DIEGO, Aug.
Drug-resistant malaria parasites have spread to critical border regions of Southeast Asia, seriously threatening global malaria control and elimination programs.
Caenorhabditis elegans is a species of parasitic roundworm in the Nematoda phylum. It can be found in temperate regions, in many different areas of the world. It prefers to reside in nutrient rich soils. Its scientific name is derived from the Greek terms Caeno, meaning recent, rhabditis, meaning rod-like, and the Latin term elegans, which means elegant. It was first named by Maupas in 1900, but was not classified in the Caenorhabditis subgenus until 1952 by Osche. Caenorhabditis elegans...
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.